CN114644617A - Cyanopyridine compound and electroluminescent device comprising the same - Google Patents

Cyanopyridine compound and electroluminescent device comprising the same Download PDF

Info

Publication number
CN114644617A
CN114644617A CN202011510063.3A CN202011510063A CN114644617A CN 114644617 A CN114644617 A CN 114644617A CN 202011510063 A CN202011510063 A CN 202011510063A CN 114644617 A CN114644617 A CN 114644617A
Authority
CN
China
Prior art keywords
compound
cyanopyridine
light emitting
synthesis
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011510063.3A
Other languages
Chinese (zh)
Inventor
郑建鸿
陈怡宽
贾亚库马
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202011510063.3A priority Critical patent/CN114644617A/en
Publication of CN114644617A publication Critical patent/CN114644617A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H10K50/12OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Pyridine Compounds (AREA)

Abstract

A cyanopyridine compound represented by chemical formula 1 and an electroluminescent device comprising the same. In chemical formula 1, R1To R3、Ar1And Ar2As described in the detailed description. [ chemical formula 1]
Figure DDA0002846121480000011

Description

Cyanopyridine compound and electroluminescent device comprising the same
Technical Field
The present invention relates to a compound, and more particularly, to a cyanopyridine compound and an electroluminescent device comprising the same.
Background
Conventional fluorescent materials can be used as emitters in Organic Light Emitting Diode (OLED) assemblies. Due to the spin selection rule (spin selection rule), the ratio of excitons used is low, which results in insufficient light emitting efficiency of the light emitting device. In the prior art, noble metals are introduced into the phosphor materials to increase Spin-Orbital Coupling (SOC) effect, thereby improving the light emitting efficiency of the light emitting device. However, since the precious metals (e.g. iridium and platinum) are expensive, the manufacturing cost of the light emitting device is also increased, which is not suitable for commercial application.
The development of Thermally Activated Delayed Fluorescence (TADF) materials has been a popular field of research in recent years, wherein TADF materials have the advantages of both high luminous efficiency and low cost. The key to making the luminescent molecule possess the property of thermally activated delayed fluorescence is to narrow down the lowest singlet excited state (S)1) And the lowest triplet excited state (T)1) Energy difference (Δ E) therebetweenST). When Δ ESTSmall enough, the endothermic Reverse Intersystem Crossing (RISC) can occur via thermal activation stimulation of the environment and capture 25% of singlet excitons and 75% of triplet excitons simultaneously during electrical excitation, thereby achieving 100% internal quantum efficiency.
However, too small Δ ESTThis results in a decrease in the ability to transition between the excited state and the ground state, and an increase in the occurrence of non-radiative paths, which in turn decreases the luminescence Quantum efficiency (PLQY). Therefore, the structural design of the light-emitting molecules determines the light-emitting characteristics of the material.
Furthermore, the Delayed Fluorescence lifetime (Delayed Fluorescence lifetime) of the typical TADF material is long, about tens to hundreds of microseconds (microsecond), while the excitons at high energy are easily quenched, which limits the efficiency performance and the operation stability of the light emitting device at high brightness, thereby reducing the reliability and lifetime performance of the typical TADF material applied to the electroluminescent device.
Disclosure of Invention
The present invention provides a cyanopyridine compound which can realize an electroluminescent module having high luminous efficiency.
The present invention provides a cyanopyridine compound represented by the following chemical formula 1:
[ chemical formula 1]
Figure BDA0002846121460000011
In the chemical formula 1, the reaction mixture is,
Ar1and Ar2May be the same or different and are each independently substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl;
R1and R2May be the same or different and are each independently substituted or unsubstituted alkyl; and
R3is a nitrogen-containing group.
In one embodiment of the present invention, R3Any one selected from the following structures:
Figure BDA0002846121460000021
in one embodiment of the present invention, Ar1And Ar2Each independently is any one selected from the following structures:
Figure BDA0002846121460000022
in one embodiment of the present invention, R1And R2Each independently being methyl, ethyl or propyl.
In an embodiment of the present invention, the cyanopyridine compound is selected from the following structural formulas:
Figure BDA0002846121460000023
Figure BDA0002846121460000031
the present invention provides an electroluminescence device, including: a cathode, an anode, and a light-emitting layer. The light-emitting layer is arranged between the cathode and the anode, and the light-emitting layer comprises the cyanopyridine compound.
In an embodiment of the invention, the light emitting layer includes a host light emitting material and a guest light emitting material.
In an embodiment of the invention, the host luminescent material includes the cyanopyridine compound.
In an embodiment of the invention, the guest light emitting material includes the cyanopyridine compound.
In an embodiment of the invention, the electroluminescent device further includes at least one auxiliary layer selected from the group consisting of a hole injection layer, a hole transport layer, a hole blocking layer, an exciton blocking layer, an electron injection layer, an electron transport layer and an electron blocking layer.
Based on the above, the cyanopyridine compound of the present example has characteristics satisfying the requirement of multiple optical rotation, high luminescence quantum efficiency, excellent thermal stability and thermally activated delayed fluorescence. The cyano pyridine-containing compound of the invention increases the electron accepting ability of the pyridine group by introducing cyano groups at the 3-and 5-positions of the pyridine group. In addition, the cyanopyridine-containing compounds of the present invention have 3, 5-dicyanopyridine as an electron-withdrawing group, thereby increasing the charge transfer properties of the whole molecule and narrowing the electron cloud overlap of HOMO and LUMO to decrease Δ ESTThereby obtaining the thermal activation delayed fluorescence characteristic and further improving the luminous efficiency of the electroluminescent device.
In addition, in the present embodiment, since the cyanopyridine-containing compound introduces the nitrogen-containing group as an electron donor at the para position of the phenyl group as the linking group, the emission color and the emission Quantum efficiency of the molecule can be controlled (PLQY). In addition, in this example, since the cyanopyridine-containing compound has an alkyl group introduced at the ortho-position of the phenyl group as the linking group, the dihedral angle (dihedral angle) between the phenyl group and the 3, 5-dicyanopyridine is increased by the steric hindrance effect between the alkyl group and the cyano group, and the overlap of the electron clouds of the HOMO and LUMO is reduced. In addition, the light-emitting layer of the electroluminescent device of the present embodiment includes the cyanopyridine compound, and thus has high external quantum efficiency and long lifetime of the light-emitting element.
In order to make the aforementioned and other features and advantages of the invention more comprehensible, embodiments accompanied with figures are described in detail below.
Drawings
FIG. 1 is a cross-sectional view of an electroluminescent device according to an embodiment of the present invention;
FIG. 2 is a cross-sectional view of an electroluminescent device according to another embodiment of the present invention;
FIG. 3 is an electron cloud distribution plot of the Molecular Orbital (MO) domains of TPAPPC, TPAsPPC and TPAmPPC;
fig. 4 is an ultraviolet-visible absorption (UV-vis absorbance) spectrum of compounds of synthesis examples 8 to 13 and synthesis comparative example 1;
FIG. 5 is a photoexcitation emission spectrum of the compounds of Synthesis examples 8 to 13 and Synthesis comparative example 1;
FIG. 6 is a room temperature fluorescence spectrum and a low temperature phosphorescence spectrum of CZmPPC according to an embodiment of the present invention;
FIG. 7 shows a room temperature fluorescence spectrum and a low temperature phosphorescence spectrum of TPAmPPC according to an embodiment of the present invention;
FIG. 8 is a room temperature fluorescence spectrum and a low temperature phosphorescence spectrum of tCzmPPC according to an embodiment of the present invention;
FIG. 9 shows a room temperature fluorescence spectrum and a low temperature phosphorescence spectrum of TPAPPC according to an embodiment of the present invention;
fig. 10 is photoexcitation emission spectra of the organic light emitting diodes of experimental examples 1 to 6;
fig. 11 is a luminance-external quantum efficiency curve of the organic light emitting diodes of experimental example 5, comparative example 1, and comparative example 2;
fig. 12 is a luminance-external quantum efficiency curve of the organic light emitting diodes of experimental example 2 and comparative example 3;
fig. 13 is a luminance-external quantum efficiency curve of the organic light emitting diode of experimental example 5 at different temperatures;
fig. 14 shows the results of the lifetime test of the light-emitting devices of experimental example 10, experimental example 11, and comparative example 4.
[ description of symbols ]
10. 20: an electroluminescence device;
102: an anode;
103: a hole transport layer;
104: a cathode;
105: an electron transport layer;
106: and a light emitting layer.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the accompanying drawings, and it should be understood that the described embodiments are some, but not all embodiments of the present invention. All other embodiments that can be derived by a person skilled in the art from the embodiments and the drawings based on the embodiments of the present invention are within the scope of the claims of the present invention.
In the description of the present invention, it should be noted that the terms "first", "second", and "third" are used for descriptive purposes only and are not to be construed as indicating or implying relative importance.
This invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete and will fully convey the concept of the invention to those skilled in the art to which the invention pertains, and the present invention will only be defined by the scope of the appended claims. In the drawings, the size and relative sizes of layers and regions may be exaggerated for clarity. It will be understood that when an element such as a layer is referred to as being "formed on" or "disposed on" another element, it can be directly on the other element or intervening elements may also be present. In contrast, when an element is referred to as being "directly formed on" or "directly disposed on" another element, there are no intervening elements present.
In the context of the present specification,
Figure BDA0002846121460000051
meaning a moiety attached to another substituent.
In the present specification, the term "substituted" means substituted by the following groups, if not otherwise defined: halogen, aryl, hydroxy, alkenyl, C1-C20Alkyl, alkynyl, cyano, trifluoromethyl, alkylamino, amino, C1-C20Alkoxy, heteroaryl, aryl with halogen substituent, aralkyl with halogen substituent, aryl with haloalkyl substituent, aralkyl with haloalkyl substituent, C with aryl substituent1-C20Alkyl, cycloalkyl, having C1-C20An amino group having an alkyl substituent, an amino group having a haloalkyl substituent, an amino group having an aryl substituent, an amino group having a heteroaryl substituent, a phosphonooxy group having an aryl substituent, a phosphonooxy group having C1-C20Alkyl-substituted phosphonoxy, phosphonooxy with haloalkyl substituent, phosphonooxy with halogen substituent, phosphonooxy with heteroaryl substituent, nitro, carbonyl, arylcarbonyl, heteroarylcarbonyl or C with halogen substituent1-C20An alkyl group.
Hereinafter, embodiments of the present invention are described in detail. However, these embodiments are illustrative, and the present invention is not limited thereto.
A cyanopyridine compound according to an embodiment of the present invention is represented by the following chemical formula 1:
[ chemical formula 1]
Figure BDA0002846121460000052
In the chemical formula 1, the first and second,
Ar1and Ar2May be the same or different and are each independently a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl;
R1and R2May be the same or different and are each independently substituted or unsubstituted alkyl; and
R3is a nitrogen-containing group.
In one embodiment of the present invention, R3Any one selected from the following structures:
Figure BDA0002846121460000053
Figure BDA0002846121460000061
in one embodiment of the present invention, Ar1And Ar2Each independently is any one selected from the following structures:
Figure BDA0002846121460000062
in one embodiment of the present invention, R1And R2Each independently methyl, ethyl or propyl.
In one embodiment of the present invention, the cyanopyridine-containing compound is selected from any one of the following structural formulas:
Figure BDA0002846121460000063
Figure BDA0002846121460000071
in this example, the cyanopyridine-containing compound of the present invention has a core structure of 3, 5-dicyanopyridine, and this core structure can serve as an electron acceptor (i.e., electron-withdrawing group). Further, the 4-position of the pyridine group of the cyanopyridine compound of the present invention is linked with a phenyl group (as a linking group), and a nitrogen-containing group (R) as an electron donor (i.e., electron donating group) is introduced at the para-position of the phenyl group3). Further, the cyanopyridine-containing compound of the present invention has alkyl groups (R) introduced at the ortho-positions of the phenyl groups as the linking groups, respectively1And R2) And in the pyridine group (as core structure)) The 2 nd and 6 th positions of the compound are respectively introduced with aryl or heteroaryl with resonance property.
Because the pyridine group has insufficient electron withdrawing capability, the cyanopyridine compound of the present invention has cyano groups introduced into the positions 3 and 5 of the pyridine group to increase the electron accepting capability of the pyridine group. In addition, the cyanopyridine compound of the present invention has 3, 5-dicyanopyridine as an electron withdrawing group to increase the charge transfer property of the whole molecule and to reduce the overlap of electron clouds of HOMO and LUMO to decrease Δ ESTTherefore, the thermal activation delayed fluorescence characteristic is obtained, and the luminous efficiency of the OLED component can be improved.
Further, in this example, since the cyanopyridine-containing compound was introduced with the nitrogen-containing group (R) as the electron donor at the para-position of the phenyl group as the linking group3) Thereby, the light emission color and the light emission Quantum efficiency of the molecule (PLQY) can be controlled. In addition, in this example, since the cyanopyridine compound was introduced with alkyl groups (R) respectively at the ortho-positions to the phenyl groups as the linking groups1And R2) The dihedral angle (dihedral angle) between the phenyl group and the 3, 5-dicyanopyridine is increased by the steric hindrance effect between the alkyl group and the cyano group, thereby achieving the purpose of reducing the electron cloud overlap of HOMO and LUMO.
Hereinafter, an organic light emitting diode according to an embodiment of the present invention will be described with reference to the drawings.
FIG. 1 is a cross-sectional view of an electroluminescent device according to an embodiment of the invention.
Referring to fig. 1, the electroluminescent device 10 of the present embodiment includes an anode 102, a cathode 104 and a light-emitting layer 106. In one embodiment, the electroluminescent device 10 is an Organic Light Emitting Diode (OLED). The light emitting layer 106 is disposed between the anode 102 and the cathode 104. The anode 102 may be made of a conductor having a high work function to assist hole injection into the light emitting layer 106. The material of the anode 102 is, for example, a metal oxide, a conductive polymer, or a combination thereof. Specifically, the metal is, for example, nickel, platinum, vanadium, chromium, copper, zinc, gold, or an alloy thereof; the metal oxide is, for example, zinc oxide, indium tin oxide(ITO) or Indium Zinc Oxide (IZO); combinations of metals and oxides, e.g. ZnO with Al or SnO2In combination with Sb; the conductive polymer is, for example, poly (3-methylthiophene), poly (3,4- (ethylene-1,2-dioxy) thiophene (poly (3,4- (ethylene-1,2-dioxy) thiophene, PEDT), polypyrrole (polypyrole), or polyaniline (polyailine), but the present invention is not limited thereto.
The cathode 104 may be made of a conductor having a low work function to assist electron injection into the light emitting layer 106. The material of the cathode 104 is, for example, a metal or a material of a multilayer structure. Specifically, the metal is, for example, magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium (gadolinium), aluminum, silver, tin, lead, cesium, barium, or an alloy thereof; the material of the multilayer structure is, for example, LiF/Al, LiO2Al, LiF/Ca, LiF/Al or BaF2The present invention is not limited thereto.
In this embodiment, the light-emitting layer 106 includes the cyanopyridine compound of the above-described embodiment. Specifically, the light-emitting layer 106 includes a mixture of at least one of the cyanopyridine-containing compounds of the above-described embodiments, at least two of the cyanopyridine-containing compounds of the above-described embodiments, or the cyanopyridine-containing compounds of the above-described embodiments with other compounds.
The light-emitting layer 106 typically includes a host light-emitting material and a guest light-emitting material. In one embodiment, the cyanopyridine-containing compound of the above embodiments can be used as a host light-emitting material to be mixed with a guest light-emitting material. In one embodiment, the light-emitting layer 106 may include a cyanopyridine-containing compound and other host light-emitting materials. In one embodiment, the cyanopyridine-containing compound of the above embodiments can be used as a guest light-emitting material and mixed with a host light-emitting material.
The host light-emitting material other than the cyanopyridine compound of the above embodiment is, for example, a condensed aromatic ring derivative (condensed aromatic ring derivative), a heterocyclic ring-containing compound (heterocyclic-containing compound), or the like. The fused aromatic ring derivative is, for example, an anthracene (anthrene) compound, a pyrene (pyrene) compound, a naphthalene (naphthalene) compound, a pentacene (pentacene) compound, a phenanthrene (phenanthrene) compound, a fluoranthene (fluoranthene) compound, or the like. The heterocycle-containing compound is, for example, a carbazole compound, a dibenzofuran (dibenzofuran) compound, a ladder-type furan (ladder-type furan) compound, a pyrimidine (pyrimidine) compound, or the like.
The guest light-emitting material other than the cyanopyridine-containing compound of the above-described embodiment is, for example, an arylamine compound, a styrylamine compound, a boron complex (boron complex), a fluoranthene compound, a metal complex, or the like. Specifically, the arylamine compound is, for example, a fused aromatic ring compound substituted with an arylamine group, and examples thereof include pyrene, anthracene, chrysene, diindenopyrene (periflanthene), and the like having an arylamine group; specific examples of the styrene amine compound include styrene amine (styryl amine), styrene diamine (styryl diamine), styrene triamine (styryl triamine), and styrene tetramine (styryl tetramine). Examples of the metal complex include iridium complex (iridium complex) and platinum complex (platinum complex), but are not limited thereto.
In one embodiment, the organic light emitting diode 10 further comprises at least one auxiliary layer selected from the group consisting of a hole injection layer, a hole transport layer, a hole blocking layer, an exciton blocking layer, an electron injection layer, an electron transport layer, and an electron blocking layer.
FIG. 2 is a cross-sectional view of an electroluminescent device according to another embodiment of the present invention. In fig. 2, the same components as those in fig. 1 will be denoted by the same reference numerals, and the description of the same technical contents will be omitted. The electroluminescent device 20 includes an anode 102, a hole transport layer 103, a light-emitting layer 106, an electron transport layer 105, and a cathode 104. In the present embodiment, the light-emitting layer 106 includes the cyanopyridine-containing compound of the above-described embodiment.
Hereinafter, the above embodiments are described in more detail with reference to examples. However, these examples are not to be construed in any way as limiting the scope of the invention.
[ theoretical calculation of Density functional ]
In this example, the compounds CzmPPC, tCzmPPC, SAcmPPC, TPAmPPC, tTPAmPPC, DP were obtained by calculation using Density Functional Theory (DFT)Optimum structure (geometrical optimization) of CzmPPC, TPAepPC, TPAiPPC, TPAmPPCcn and TPAmPPCph, and singlet excited state energy (E)S) Triplet excited state energy (E)T)、ΔESTAnd dihedral angles, and further predict the possibility of the cyanopyridine-containing compounds of the present invention as Thermally Activated Delayed Fluorescence (TADF) materials.
In this example, using Gaussian09 as the computing software, B3LYP calculations were performed and the transition energy from the ground state to the excited state and the electron cloud distribution were calculated with Time-dependent density functional theory (TD-DFT) with 6-31G as the basis function (basis set).
The results of theoretical calculations are shown in table 1 below, where the dihedral angle (dihedral angle) is defined as the angle between the 3, 5-dicyanopyridine and the phenyl group in position 4.
[ Table 1]
Figure BDA0002846121460000091
Figure BDA0002846121460000101
Figure BDA0002846121460000111
From the results shown in Table 1, it is understood that the singlet excited state energy (E) of the cyanopyridine-containing compound of the present invention is theoretically calculatedS) With energy of triplet excited state (E)T) Difference Δ E betweenST0.0001-0.078 eV, and a dihedral angle of 73.7-89.1 deg. The above-mentioned low Δ E can be achievedSTAnd the reason for the high dihedral angle is that the steric hindrance between the alkyl group at the ortho position on the phenyl group of the cyanopyridine-containing compound and the cyano group at the 3-and 5-positions of the pyridyl group shifts the two planes to be nearly orthogonal, making the orbital overlap between the HOMO and LUMO small, thereby reducing Δ ESTThus, it is presumed that the cyanopyridine compounds of the present invention are thermally activatedDelayed fluorescence properties.
In this example, compounds TPAPPC, TPAsPPC were used as comparative examples. In the structure of compound TPAPPC, in the ortho position (R) of the benzene ring to which the pyridine-3, 5-dicyano group is attached1And R2) Has no substituent, i.e. R1And R2Are both hydrogen. And in the structure of the compound TPAsPPC, R1Is hydrogen, and R2Is methyl.
Figure BDA0002846121460000112
Calculating by density functional theory to obtain electron cloud distribution and Delta E of Molecular Orbital (MO) of compounds TPAPPC, TPAsPPC and TPAmPPCSTAnd dihedral angles. The results of the theoretical calculations are shown in table 2 below.
[ Table 2]
Compound (I) ΔEST(eV) Two-sided angle (°)
TPAPPC 0.224 50.4
TPAsPPC 0.025 68.2
TPAmPPC 0.015 73.8
FIG. 3 is an electron cloud distribution diagram of the Molecular Orbital (MO) domains of TPAPPC, TPAsPPC and TPAmPPC. As is clear from the results of table 2 and fig. 3, the electron cloud of the HOMO of the compound TPAmPPC is concentrated on the electron acceptor (i.e., electron-withdrawing group), and the electron cloud of the LUMO of the compound TPAmPPC is concentrated on the electron donor (i.e., electron-withdrawing group). In addition, because the alkyl group at the ortho position on the phenyl group of the compound TPAmPPC is close to the pyridyl group, the alkyl group on the phenyl group and the cyano group on the pyridyl group create a steric barrier, which allows good separation of HOMO and LUMO (i.e., the overlap of the orbital regions between HOMO and LUMO is small), thereby reducing Δ EST(only 0.015).
The trans-compound TPAPPC and TPAsPPC have a dihedral angle of only 50.4-68.2 DEG because of lack of sufficient steric hindrance at the ortho-position of the linking group (i.e., phenyl group) of the compounds TPAPPC and TPAsPPC, and the electron cloud of HOMO extends to the pyridine group, resulting in large overlap of the rail regions between HOMO and LUMO, and thus Δ ESTAnd (4) increasing.
Synthesis of organic compounds
[ intermediate Synthesis ]
Synthesis example 1: synthesis of intermediate I-1(4- (9H-carbazol-9-yl) -2,6-dimethylbenzaldehyde)
[ reaction scheme 1]
Figure BDA0002846121460000121
The compound 9- (4-bromo-3, 5-dimethylphenyl) -9H-carbazole (1g,2.9mmol) was added to a two-necked flask, stoppered with serum, dried Tetrahydrofuran (THF) (19mL,0.15M) was added via the side port, and the system was cooled to-78 ℃ with an acetone bath. N-butyllithium (n-butylllithium, n-BuLi) (1.73mL,4.3mmol) was slowly added to the flask in a plastic syringe under nitrogen to form an orange solution, and the acetone bath was maintained for 1 hour. Then, dry Dimethylformamide (DMF) (0.64g,8.7mmol) was added by syringe under nitrogen atmosphere, and the acetone bath was maintained for 1 hour, and the reaction was carried out overnight. After the reaction was complete, water was added and excess base was neutralized with aqueous hydrochloric acid. Extracted 3 times with ethyl acetate and concentrated by rotation. Then, the product was purified by column chromatography (eluent was ethyl acetate/n-hexane 1/19, v/v) to obtain intermediate I-1(0.69g, yield 80.0%) as a white solid.
1H NMR(500MHz,CDCl3,δ):10.67(s,1H),8.12(d,J=8.0Hz,2H),7.48(d,J=8.5Hz,2H),7.42(t,J=8.0Hz,2H),7.34(s,2H),7.30(t,J=7.5Hz,2H),2.72(s,6H).13C NMR(125MHz,CDCl3,δ):192.41,143.51,141.58,140.11,130.91,127.17,126.13,123.79,120.52,120.43,109.92,20.80.
Synthesis example 2: synthesis of intermediate I-2(4- (3,6-di-tert-butyl-9H-carbazol-9-yl) -2,6-dimethylbenzaldehyde)
[ reaction scheme 2]
Figure BDA0002846121460000122
The compound 9- (4-bromo-3, 5-dimethylphenyl) -3, 6-di-tert-butyl-9H-carbazole (1g,2.2mmol) was added in a two-necked flask, stoppered with serum, dried Tetrahydrofuran (THF) (14mL,0.15M) was added via the side port, and the system was cooled to-78 ℃ with an acetone bath. N-butyllithium (1.31mL,3.2mmol) was added slowly with a plastic needle under nitrogen to form an orange solution, and the acetone bath was maintained for 1 hour. Then, dry Dimethylformamide (DMF) (0.47g,6.5mmol) was added by syringe under nitrogen, and the acetone bath was maintained for 1 hour, and the reaction was carried out overnight. After the reaction was completed, water was added and the excess alkali was neutralized with an aqueous hydrochloric acid solution. Extracted 3 times with ethyl acetate and concentrated by rotation. Then, the product was purified by column chromatography (using ethyl acetate/n-hexane 1/19, v/v) to obtain intermediate I-2(0.6g, yield 67.4%) as a white solid.
1H NMR(500MHz,CDCl3,δ):10.66(s,1H),8.12(s,2H),7.45(q,J=8.5Hz,4H),7.33(s,2H),2.71(s,6H),1.45(s,18H).13C NMR(125MHz,CDCl3,δ):192.34,143.56,143.47,142.13,138.38,130.39,126.58,123.87,123.78,116.37,109.44,34.75,31.95,20.84.
Synthesis example 3: synthesis of intermediate I-3(4- (5H-dibenzo [ b, f ] azepin-5-yl) -2,6-dimethylbenzaldehyde) (4- (5H-dibenz [ b, f ] azepin-5-yl) -2,6-dimethylbenzaldehyde)
[ reaction scheme 3]
Figure BDA0002846121460000131
The compound 5- (4-bromo-3, 5-dimethylphenyl) -5H-dibenzo [ b, f ] azepine (0.3g,0.8mmol) was charged in a two-necked flask, stoppered with serum, dried Tetrahydrofuran (THF) (8mL,0.1M) was added through the side port, and the system was cooled to-78 ℃ with an acetone bath. N-butyllithium (0.48mL,1.8mmol) was slowly added with a plastic needle under nitrogen to form an orange solution, and the acetone bath was maintained for 1 hour. Then, dry Dimethylformamide (DMF) (0.18g,2.4mmol) was added by syringe under nitrogen atmosphere, and the acetone bath was maintained for 1 hour, and the reaction was carried out overnight. After the reaction was completed, water was added and the excess alkali was neutralized with an aqueous hydrochloric acid solution. Extracted 3 times with ethyl acetate and concentrated by rotation. Then, the product was purified by column chromatography (eluent was ethyl acetate/n-hexane 1/19, v/v) to obtain intermediate I-3(0.14g, yield 53.3%) as a yellow solid.
1H NMR(500MHz,CDCl3,δ):10.28(s,1H),7.51(t,J=7.5Hz,2H),7.44(d,J=8.0Hz,4H),7.38(t,J=7.5Hz,2H),6.85(s,2H),5.91(s,2H),2.37(s,6H).13C NMR(125MHz,CDCl3,δ):190.76,151.93,143.82,141.45,135.72,130.45,130.32,129.83,129.48,127.57,123.53,112.27,21.42.
Synthesis example 4: synthesis of intermediate I-4(2, 6-dimethyl-4- (10H-spiro [ [ pyridine-9, 9 '-fluorene ] -10-yl ] benzaldehyde) (2,6-dimethyl-4- (10H-spiro [ acridine-9,9' -fluoro ] -10-yl) benzaldehyde) ("2, 6-dimethyl-4-")
[ reaction scheme 4]
Figure BDA0002846121460000132
The compound 10- (4-bromo-3, 5-dimethylphenyl) -10H-spiro [ acridine-9,9' -fluorene ] (1g,1.9mmol) was added to a two-necked flask, stoppered with serum, and dried Tetrahydrofuran (THF) (24mL,0.08M) was added via the side port, and the system was cooled to-78 ℃ with an acetone bath; n-butyllithium (1.16mL,2.9mmol) was slowly added with a plastic needle under nitrogen to form an orange solution, and the acetone bath was maintained for 1 hour. Then, dry Dimethylformamide (DMF) (0.43g,5.7mmol) was added by syringe under nitrogen atmosphere, and the acetone bath was maintained for 1 hour, and the reaction was carried out overnight. After the reaction was complete, water was added and excess base was neutralized with aqueous hydrochloric acid. Extracted 3 times with ethyl acetate and concentrated by rotation. Then, the product was purified by column chromatography (eluent was ethyl acetate/n-hexane 1/19, v/v) to obtain intermediate I-4(0.61g, yield 67.2%) as a yellow solid.
1H NMR(500MHz,CDCl3,δ):10.72(s,1H),7.77(d,J=7.5Hz,2H),7.38-7.33(m,4H),7.23-7.21(m,4H),6.90(t,J=7.5Hz,2H),6.55(t,J=7.5Hz,2H),6.38(d,J=7.5Hz,2H),6.34(d,J=7.5Hz,2H),2.72(s,6H).13C NMR(125MHz,CDCl3,δ):192.87,156.52,144.96,144.44,140.59,139.19,132.40,132.13,128.37,127.96,127.62,127.23,125.72,124.80,120.86,119.91,114.46,20.67.
Synthesis example 5: synthesis of intermediate I-5(4- (diphenylamino) -2,6-dimethylbenzaldehyde)
[ reaction scheme 5]
Figure BDA0002846121460000141
The compound 4-bromo-3, 5-dimethyl-N, N-diphenylaniline (1g,2.8mmol) was added to a two-necked flask, stoppered with serum, and dried Tetrahydrofuran (THF) (28mL,0.1M) was added via the side port, and the system was cooled to-78 ℃ with an acetone bath; n-butyllithium (1.7mL,4.3mmol) was slowly added with a plastic needle under nitrogen to form an orange solution, and the acetone bath was maintained for 1 hour. Then, dry Dimethylformamide (DMF) (0.64g,8.7mmol) was added by syringe under nitrogen atmosphere, and the acetone bath was maintained for 1 hour, and the reaction was carried out overnight. After the reaction was completed, water was added and the excess alkali was neutralized with an aqueous hydrochloric acid solution. Extracted 3 times with ethyl acetate and concentrated by rotation. Then, the product was purified by column chromatography (eluent was ethyl acetate/n-hexane 1/19, v/v) to obtain intermediate I-5(0.66g, yield 77.4%) as a pale yellow solid.
1H NMR(500MHz,CDCl3,δ):10.39(s,1H),7.31(t,J=8.0Hz,4H),7.15-7.12(m,6H),6.58(s,2H),2.47(s,6H).13C NMR(125MHz,CDCl3,δ):191.18,151.60,146.22,143.61,129.58,126.26,125.39,124.76,120.27,21.10.
Synthesis example 6: synthesis of intermediate I-6(4- (bis (4- (tert-butyl) phenyl) amino) -2,6-dimethylbenzaldehyde)
[ reaction scheme 6]
Figure BDA0002846121460000142
The compound 4-bromo-N, N-bis (4- (tert-butyl) phenyl) -3, 5-dimethylaniline (0.5g,1.1mmol) was added to a two-necked flask, stoppered with serum, and dried Tetrahydrofuran (THF) (11mL,0.1M) was added via the side port, and the system was cooled to-78 ℃ with an acetone bath; n-butyllithium (0.6mL,1.6mmol) was slowly added with a plastic needle under nitrogen to form an orange solution, and the acetone bath was maintained for 1 hour. Then, dry Dimethylformamide (DMF) (0.2g,3.2mmol) was added by syringe under nitrogen, and the acetone bath was maintained for 1 hour, and the reaction was carried out overnight. After the reaction was completed, water was added and the excess alkali was neutralized with an aqueous hydrochloric acid solution. Extracted 3 times with ethyl acetate and concentrated by rotation. Then, the product was purified by column chromatography (eluent was ethyl acetate/n-hexane 1/19, v/v) to obtain intermediate I-6(0.4g, yield 88.0%) as a yellow solid.
1H NMR(500MHz,CDCl3,δ):10.38(s,1H),7.31(d,J=8.4Hz,4H),7.05(d,J=8.4Hz,4H),6.55(s,2H),2.48(s,6H),1.32(s,18H).13C NMR(125MHz,CDCl3,δ):190.98,151.90,147.79,143.61,143.28,126.40,125.89,124.64,119.15,34.44,31.37,21.19.
Synthesis example 7: synthesis of intermediate I-7(4- (diphenylamino) -benzaldehyde)
[ reaction scheme 7]
Figure BDA0002846121460000151
Trianiline (2g,8.2mmol) was added to a two-necked flask, dry Dimethylformamide (DMF) (12mL,0.4M) was added via syringe, and the mixture was pumped three times and the system was cooled to 0 ℃. Phosphorus oxychloride (6.3g,40.8mmol) was added slowly with a plastic needle under nitrogen, the ice bath was removed, and after returning to room temperature, it was heated at 45 ℃ for three hours. After the reaction was completed, a large amount of ice water was added to terminate the reaction, and a yellow solid precipitate was collected with a ceramic funnel. Then, it was purified by column chromatography (eluent: ethyl acetate/n-hexane 1/19, v/v) to obtain intermediate I-7(1.98g, yield 88.8%) as a yellow solid.
1H NMR(500MHz,CDCl3,δ):10.39(s,1H),7.31(t,J=8.0Hz,4H),7.15-7.12(m,6H),6.58(s,2H),2.47(s,6H).13C NMR(125MHz,CDCl3,δ):191.18,151.60,146.22,143.61,129.58,126.26,125.39,124.76,120.27,21.10.
[ Synthesis of Final Compound ]
Synthesis example 8: synthesis of the compound 4- (4- (9H-carbazol-9-yl) -2,6-dimethylphenyl) -2,6-diphenylpyridine-3, 5-dicyano (4- (4- (9H-carbazol-9-yl) -2, 6-dimethyphenyl) -2,6-diphenylpyridine-3,5-dicarbonitrile, CzmPPC)
[ reaction scheme 8]
Figure BDA0002846121460000152
Intermediate I-7(0.67g,2.2mmol), benzoylacetic acidNitrile (0.81g,5.6mmol), ammonium acetate (0.43g,5.6mmol) were added to a two-necked flask in the presence of acetic acid (6.7mL), heated to 110 deg.C and refluxed for 12 hours. After the reaction was completed, the reaction mixture was returned to room temperature, and 2, 3-dichloro-5, 6-dicyan-p-benzoquinone (1.5g,6.6mmol) was added to a two-necked flask, heated to 110 ℃ and refluxed for 2 hours to effect oxidation. And returning to room temperature after the reaction is finished, pumping, filtering, washing off redundant acetic acid by water, and removing the solvent and the water in high vacuum to obtain a crude product. Purification via column chromatography gave the product CzmPPC as a white solid (0.69g, 57.2% overall yield). Finally, a sublimator is used for high vacuum (5 multiplied by 10)-6torr) the product was refined at a sublimation temperature of 240 ℃.
1H NMR(500MHz,CDCl3,δ):8.19-8.15(m,6H),7.62-7.61(m,6H),7.55(d,J=8.0Hz,2H),7.51(s,2H),7.46(t,J=8.0Hz,2H),7.31(t,J=7.5Hz,2H),2.31(s,6H).13C NMR(125MHz,CDCl3,δ):163.12,160.71,140.56,139.36,137.12,136.06,132.50,131.68,129.52,128.91,126.75,126.04,123.50,120.28,120.15,115.05,110.01,106.45,20.29.HRMS(FD)m/z:[M+]calcd.for C39H26N4,550.2152;found,550.2151.Anal.calcd.for C39H26N4:C 85.07,H 4.76,N 10.17found:C85.17,H 4.51,N 10.03.
Synthesis example 9: synthesis of the Compound 4- (4- (3,6-di-tert-butyl-9H-carbazol-9-yl) -2,6-dimethylphenyl) -2,6-diphenylpyridine-3, 5-dicyano (4- (4- (3,6-di-tert-butyl-9H-carbazol-9-yl) -2,6-dimethylphenyl) -2, 6-dimethylphenylpyridine-3, 5-dicarbonitrile, tCzmPPC)
[ reaction scheme 9]
Figure BDA0002846121460000161
Intermediate I-2(0.2g,0.5mmol), benzoylacetonitrile (0.18g,1.2mmol), ammonium acetate (0.11g,1.5mmol) were added to a two-necked flask in the presence of acetic acid (5mL), heated to 110 deg.C and refluxed for 12 hours. After the reaction was completed, the reaction mixture was returned to room temperature, and 2, 3-dichloro-5, 6-dicyan-p-benzoquinone (0.34g,1.5mmol) was added to a two-necked flask, heated to 110 ℃ and refluxed for 2 hoursTo perform an oxidation reaction. And returning to room temperature after the reaction is finished, performing suction filtration, washing off redundant acetic acid by water, and removing the solvent and the water in high vacuum to obtain a crude product. Purification was performed via column chromatography to give the product, tCzmPPC (0.23g, 68.1% overall yield). Finally, a sublimator is used for high vacuum (5 multiplied by 10)-6torr) the product was refined at a sublimation temperature of 265 ℃.
1H NMR(500MHz,CDCl3,δ):8.15-8.13(m,6H),7.60(m,6H),7.48(m,6H),2.27(s,6H),1.46(s,18H).13C NMR(125MHz,CDCl3,δ):163.10,160.84,143.10,139.89,138.89,136.92,136.11,131.90,131.65,129.53,128.91,126.24,123.69,123.54,116.20,115.06,109.49,106.57,34.73,31.99,20.29.HRMS(FD)m/z:[M+]calcd.for C47H42N4,662.3404;found,662.3405.Anal.calcd.for C47H42N4:C 85.16,H 6.39,N 8.45found:C 85.56,H 5.98,N 8.51.
Synthesis example 10: synthesis of the compound 4- (4- (5H-dibenzo [ b, f ] azepine-5-yl) -2,6-dimethylphenyl) -2,6-diphenylpyridine-3, 5-dicyano (4- (4- (5H-dibenz [ b, f ] azepin-5-yl) -2, 6-dimethyphenyl) -2,6-diphenylpyridine-3,5-dicarbonitrile, DBAZmPP)
[ reaction scheme 10]
Figure BDA0002846121460000171
Intermediate I-3(0.2g,0.6mmol), benzoylacetonitrile (0.22g,1.5mmol), and ammonium acetate (0.14g,1.8mmol) were added to a two-necked flask in the presence of acetic acid (5.5mL), heated to 110 deg.C, and refluxed for 12 hours. After the reaction was completed, the reaction mixture was returned to room temperature, and 2, 3-dichloro-5, 6-dicyan-p-benzoquinone (0.41g,1.8mmol) was added to a two-necked flask, and the mixture was heated to 110 ℃ to conduct oxidation for 2 hours. And returning to room temperature after the reaction is finished, performing suction filtration, washing off redundant acetic acid by water, and removing the solvent and the water in high vacuum to obtain a crude product. Purification was performed via column chromatography to give DBAZmPPC as a yellow product (0.21g, total yield 60.3%). Finally, a sublimator is used for high vacuum (5 multiplied by 10)-6torr) the product was refined, sublimation temperatureThe degree was 260 ℃.
1H NMR(500MHz,CDCl3,δ):8.05(d,J=7.5Hz,4H),7.54-7.52(m,8H),7.49(t,J=8.0Hz,2H),7.44(d,J=7.5Hz,2H),7.35(t,J=7.5Hz,2H),6.87(s,2H),6.11(s,2H),1.92(s,6H).13C NMR(125MHz,CDCl3,δ):162.75,162.23,149.75,142.44,136.36,136.30,135.13,131.27,130.67,130.21,130.20,129.60,129.45,128.74,127.11,123.09,115.44,111.51,107.58,20.48.HRMS(FD)m/z:[M+]calcd.for C41H28N4,576.2309;found,576.2303.Anal.calcd.for C41H28N4:C 85.39,H4.89,N 9.72found:C 85.23,H 4.66,N 9.70.
Synthesis example 11: synthesis of the compound 4- (2,6-dimethyl-4- (10H-spiro [ [ pyridine-9, 9 '-fluorene ] -10-yl) phenyl) -2,6-diphenylpyridine-3, 5-dicyano (4- (2,6-dimethyl-4- (10H-spiro [ acid-9, 9' -fluoro ] -10-yl) phenyl) -2,6-diphenylpyridine-3,5-dicarbonitrile, SAcmPPC)
[ reaction scheme 11]
Figure BDA0002846121460000172
Intermediate I-4(0.2g,0.4mmol), benzoylacetonitrile (0.16g,1.1mmol), ammonium acetate (0.1g,1.3mmol) were added to a two-necked flask in acetic acid (5.5mL) as the solvent, heated to 110 deg.C and refluxed for 12 hours. After the reaction was completed, the reaction mixture was returned to room temperature, and 2, 3-dichloro-5, 6-dicyan-p-benzoquinone (0.27g,1.2mmol) was added to a two-necked flask, heated to 110 ℃ and refluxed for 2 hours to effect oxidation. And returning to room temperature after the reaction is finished, pumping, filtering, washing off redundant acetic acid by water, and removing the solvent and the water in high vacuum to obtain a crude product. Purification was performed via column chromatography to give the yellow product SAcmPPC (0.15g, 51.4% overall yield). Finally, a sublimator is used for high vacuum (5 multiplied by 10)-6torr) the product was refined with a sublimation temperature of 310 ℃.
1H NMR(500MHz,CDCl3,δ):8.19(d,J=7.5Hz,4H),7.79(d,J=7.5Hz,2H),7.62-7.61(m,6H),7.43-7.42(m,4H),7.37(t,J=7.5Hz,2H),7.26(d,J=7.5Hz,2H),6.98(t,J=7.5Hz,2H),6.58(t,J=7.5Hz,2H),6.49(d,J=8.5Hz,2H),6.41(d,J=8.0Hz,2H),2.33(s,6H).13C NMR(125MHz,CDCl3,δ):163.09,160.88,156.52,142.69,140.93,139.21,138.48,136.07,133.97,131.74,131.10,129.55,129.53,128.95,128.35,127.73,127.57,127.48,125.77,124.75,120.76,119.88,115.06,114.67,106.37,20.27.HRMS(FD)m/z:[M+]calcd.for C52H34N4,714.2778;found,714.2783.Anal.calcd.for C52H34N4:C 87.37,H 4.79,N 7.84found:C 87.56,H 4.38,N 7.91.
Synthesis example 12: synthesis of 4- (4- (diphenylamino) -2,6-dimethylphenyl) -2,6-diphenylpyridine-3, 5-dicyano (4- (4- (diphenylamino) -2,6-dimethylphenyl) -2,6-diphenylpyridine-3,5-dicarbonitrile, TPAmPPC)
[ reaction scheme 12]
Figure BDA0002846121460000181
Intermediate I-5(0.2g,0.7mmol), benzoylacetonitrile (0.24g,1.7mmol), and ammonium acetate (0.15g,2.0mmol) were added to a two-necked flask in the presence of acetic acid (6mL), heated to 110 deg.C, and refluxed for 12 hours. After the reaction was completed, the reaction mixture was returned to room temperature, and 2, 3-dichloro-5, 6-dicyan-p-benzoquinone (0.48g,2.1mmol) was added to a two-necked flask, heated to 110 ℃ and refluxed for 2 hours to effect oxidation. And returning to room temperature after the reaction is finished, pumping, filtering, washing off redundant acetic acid by water, and removing the solvent and the water in high vacuum to obtain a crude product. Purification was performed via column chromatography to give the product TPAmPPC (0.21g, 54.1% overall yield). Finally, a sublimator is used for high vacuum (5 multiplied by 10)-6torr) and a sublimation temperature of 230 ℃.
1H NMR(500MHz,CDCl3,δ):8.10(d,J=7.5Hz,4H),7.57-7.56(m,6H),7.29(t,J=7.5Hz,4H),7.16(d,J=8.0Hz,4H),7.06(t,J=7.5Hz,2H),6.87(s,2H),2.04(s,6H).13C NMR(125MHz,CDCl3,δ):162.85,161.70,149.20,147.18,136.21,135.84,131.41,129.45,129.38,128.78,126.68,125.36,123.54,121.41,115.27,107.11,20.21.HRMS(FD)m/z:[M+]calcd.for C39H28N4,552.2309;found,552.2313.Anal.calcd.for C39H28N4:C 84.76,H 5.11,N 10.14found:C 85.09,H4.78,N 10.08.
Synthesis example 13: synthesis of 4- (4- (Bis (4- (tert-butyl) phenyl) amino) -2,6-dimethylphenyl) -2,6-diphenylpyridine-3, 5-dicyano (4- (4- (tert-butyl) phenyl) amino) -2,6-dimethylphenyl) -2,6-diphenylpyridine-3,5-dicarbonitrile, tTPAmPPC)
[ reaction scheme 13]
Figure BDA0002846121460000191
I-6(0.4g,0.9mmol), benzoylacetonitrile (0.4g,2.4mmol), ammonium acetate (0.2g,2.9mmol) were added to a two-necked flask in acetic acid (15mL) as a solvent, heated to 110 deg.C and refluxed for 12 hours. After the reaction was completed, the reaction mixture was returned to room temperature, and 2, 3-dichloro-5, 6-dicyan-p-benzoquinone (0.61g,2.7mmol) was added to a two-necked flask, heated to 110 ℃ and refluxed for 2 hours to effect oxidation. And returning to room temperature after the reaction is finished, pumping, filtering, washing off redundant acetic acid by water, and removing the solvent and the water in high vacuum to obtain a crude product. Purification was performed via column chromatography to give the product tpamppc (0.34g, total yield 57.0%). Finally, a sublimator is used for high vacuum (5 multiplied by 10)-6torr) the product was refined at a sublimation temperature of 260 ℃.
1H NMR(500MHz,CDCl3,δ):8.10(d,J=7.2Hz,4H),7.57-7.56(m,6H),7.29(d,J=7.8Hz,4H),7.09(d,J=7.9Hz,4H),6.85(s,2H),2.05(s,6H),1.32(s,18H).13C NMR(125MHz,CDCl3,δ):162.83,161.95,149.55,146.31,144.47,136.30,135.64,131.37,129.49,128.80,126.17,125.97,124.90,120.78,115.34,34.33,31.42,20.27.HRMS(EI)m/z:[M+]calcd.for C47H44N4,664.3566;found,664.3564.Anal.calcd.for C47H44N4:C 84.90,H 6.67,N 8.43found:C 84.78,H 6.55,N 8.33.
Synthesis of comparative example 1: synthesis of 4- (4- (diphenylamino) phenyl) -2,6-diphenylpyridine-3, 5-dicyano (4- (4- (diphenylamino) phenyl) -2,6-diphenylpyridine-3,5-dicarbonitrile, TPAPPC)
[ reaction scheme 14]
Figure BDA0002846121460000192
Intermediate I-7(1.0g,3.7mmol), benzoylacetonitrile (1.2g,8mmol), and ammonium acetate (1.3g,16.5mmol) were added to a two-necked flask in the presence of acetic acid (29mL), heated to 110 deg.C and refluxed for 12 hours. After the reaction was completed, the reaction mixture was returned to room temperature, and 2, 3-dichloro-5, 6-dicyan-p-benzoquinone (2.5g,11.1mmol) was added to a two-necked flask in the presence of acetic acid (20mL) as a solvent, and the mixture was heated to 110 ℃ and refluxed for 2 hours to effect oxidation. And returning to room temperature after the reaction is finished, pumping, filtering, washing off redundant acetic acid by water, and removing the solvent and the water in high vacuum to obtain a crude product. Purification was performed via column chromatography to give TPAPPC (1.5g, total yield 78.0%) as a yellow product. Finally, a sublimator is used for high vacuum (5 multiplied by 10)-6torr) the product was refined at a sublimation temperature of 240 ℃.
1H NMR(500MHz,CDCl3,δ):8.03(d,J=7.3Hz,6H),7.55-7.54(m,2H),7.48(d,J=8.6Hz,4H),7.32(t,J=7.6Hz,4H),7.21(d,J=7.8Hz,4H),7.13(dd,J=13.8,7.9Hz,4H).13C NMR(125MHz,CDCl3,δ):163.55,155.96,150.44,146.52,136.60,131.21,130.34,129.64,129.55,128.71,126.09,124.91,124.55,120.12,116.41,105.57.HRMS(EI)m/z:[M+]calcd.for C37H24N4,524.2001;found,524.2006.Anal.calcd.for C37H24N4:C 84.71,H 4.61,N 10.68found:C 84.64,H4.43,N 10.59.
In this example, Nuclear Magnetic Resonance (NMR) spectra of the above compounds were measured by a spectrometer (Varian Mercury 500). Hydrogen nuclear magnetic resonance spectrum (1H NMR) in CDCl3For the standard, the chemical shift (chemical shift) was defined as 7.24ppm, the symbol s represents a singlet (singlet), d represents a doublet (doubtet), t represents a triplet (triplet), and m represents a multiplet (multiplet)Dd denotes a doublet of doublets (doublets) and the coupling constant (coupling constant) is in Hz.13Chemical shifts of the C NMR spectrum in CDCl3As a standard, the chemical shift was 77.0 ppm. High resolution mass spectra were determined using a JEOL AccuTOF GCx HRGCMS or JEOL JMS-700HRMS mass spectrometer. The weight percentages of carbon, hydrogen, nitrogen and sulfur in the sample were determined by an Elemental analyzer (elementary analyzer) which is a fully automatic Elemental analyzer, vario EL III CHN-OS Rapid (elmendor).
[ evaluation of Properties of Compounds ]
[ photophysical Properties ]
[ ultraviolet-visible absorption Spectroscopy and photoexcitation Spectroscopy ]
The compounds of Synthesis examples 8 to 13 and Synthesis comparative example 1 were placed in 10-5M in a toluene solution, calibration was performed in a quartz sample cell, and ultraviolet-visible absorption (UV-vis absorption) spectra of the compounds of synthesis examples 8 to 13 and synthesis comparative example 1 were measured by a spectrophotometer (spectrophotometer) Hitach U-3300, and Photoexcitation (PL) spectra of the compounds of synthesis examples 8 to 13 and synthesis comparative example 1 were measured by a fluorescence spectrometer (fluorescence spectrophotometer) Hitach F-7000.
[ ultraviolet photoelectron spectroscopy ]
In the present example, electron dissociation energies of the compounds of synthesis examples 8 to 13 and synthesis comparative example 1 in a thin film state were measured using a photoelectron spectrometer (photoelectron spectrometer) to obtain an ultraviolet photoelectron spectrum. Specifically, each sample was formed as an undoped film and set on a glass substrate, and the surface of the film was irradiated with ultraviolet light. Because of the small attraction between the valence electrons and the nuclei of the surface layer of the compound, the valence electrons are ejected away from the surface after absorbing high energy and form negatively charged O with oxygen2 -The initial energy at which electrons are accelerated into the detector under an electric field and begin to be detected by the instrument is the HOMO level of the compound in electron volts (eV). The energy difference (energy gap, E) from the ground state to the singlet excited state is calculated from the initial value (onset) of the absorption spectrumg) Then is further prepared byHOMO and EgThe LUMO energy level of the compound was calculated.
The results of synthesizing the ultraviolet-visible absorption spectrum, the photoexcitation spectrum, and the ultraviolet photoelectron spectrum of the compounds of examples 8 to 13 and comparative example 1 are shown in table 3 below. Fig. 4 is an ultraviolet-visible absorption (UV-vis absorbance) spectrum of the compounds of synthesis examples 8 to 13 and synthesis comparative example 1. Fig. 5 is a photoexcitation emission spectrum of the compounds of synthesis examples 8 to 13 and synthesis comparative example 1.
[ Table 3]
Synthesis examples λabs(nm) λTol(nm) Eg(eV) HOMO(eV) LUMO(eV)
CzmPPC 292 482 3.07 -5.82 -2.75
tCzmPPC 298 502 2.92 -5.72 -2.80
DBAZmPPC 288 526 2.73 -5.72 -2.99
SAcmPPC 296 534 2.68 -5.61 -2.93
TPAmPPC 302 544 2.61 -5.69 -3.08
tTPAmPPC 304 564 2.53 -5.60 -3.07
Comparative example of Synthesis λabs(nm) λTol(nm) Eg(eV) HOMO(eV) LUMO(eV)
TPAPPC 290 503 2.64 -5.76 -3.12
λabs: absorption wavelength in toluene
λTol: emission wavelength in toluene
As can be seen from the results shown in Table 3 and FIGS. 4 to 5, the HOMO level of the cyanopyridine-containing compounds of the present invention is in the range of-5.82 eV to-5.60 eV, and the LUMO level is in the range of-3.12 eV to-2.75 eV. In addition, the light emission of the cyanopyridine-containing compound of the present invention covers blue light, green light to yellow light, and the light emission wavelength is between 482nm and 564 nm. That is, with the nitrogen-containing group (R) at the para-position on the phenyl group3) The cyanopyridine-containing compounds of the present invention have different light emission colors. That is, the cyanopyridine compound of the present invention satisfies the requirement of multiple optical activities. Thus, the present invention can be achieved by changing the nitrogen-containing group (R) of the cyanopyridine-containing compound3) The structure of (a) to control the color of emission of cyanopyridine-containing compounds.
[ Room temperature fluorescence Spectroscopy and Low temperature phosphorescence Spectroscopy ]
The compounds of synthesis examples 8 to 13 and synthesis comparative example 1 were doped at 10 wt% in a host material, mCPCN, which was evaporated on a quartz plate at 30nm to form a thin film, and placed in a transparent quartz tube. The room temperature fluorescence spectrum and the low temperature phosphorescence spectrum were measured by a fluorescence spectrometer (fluorescence spectrophotometer) Hitach F-7000. In this example, the measurement temperature of the room temperature fluorescence spectrum is 298K, and the measurement temperature of the low temperature phosphorescence spectrum is 77K. Calculation of E from the starting wavelength of the fluorescence SpectroscopySCalculating E as the starting wavelength of the phosphorescence spectrumTThe two are subtracted to obtain Delta ESTIn electron volts (eV). ChamberThe results of the warm fluorescence spectrum and the low temperature phosphorescence spectrum are shown in table 4 below.
Figure BDA0002846121460000211
[ measurement of luminescence quantum efficiency ]
The compounds of synthesis examples 8 to 13 and synthesis comparative example 1 were doped with 10 wt% of a host emitter mCPCN, and the above materials were deposited on a quartz plate to form a thin film by 30 nm. The calibration was performed with a blank quartz plate, and then the luminescent quantum efficiency (PLQY) of the film sample on the quartz plate was measured under nitrogen using an integrating sphere (integrating sphere).
[ Table 4]
Synthesis examples ES(eV) ET(eV) ΔEST(eV) ΦPLQY(%)
CzmPPC 2.95 2.68 0.27 92
tCzmPPC 2.82 2.70 0.12 97
DBAZmPPC 2.80 2.78 0.02 24
SAcmPPC 2.73 2.68 0.05 100
TPAmPPC 2.69 2.67 0.02 100
tTPAmPPC 2.60 2.58 0.02 79
Comparative example of Synthesis ES(eV) ET(eV) ΔEST(eV) ΦPLQY(%)
TPAPPC 2.73 2.52 0.21 100
FIG. 6 shows the room temperature fluorescence spectrum and the low temperature phosphorescence spectrum of CZmPPC according to example of the present invention. Fig. 7 shows a room temperature fluorescence spectrum and a low temperature phosphorescence spectrum of TPAmPPC according to an embodiment of the present invention. FIG. 8 shows the room temperature fluorescence spectrum and the low temperature phosphorescence spectrum of tCzmPPPC according to example of the present invention. FIG. 9 shows a room temperature fluorescence spectrum and a low temperature phosphorescence spectrum of TPAPPC according to an embodiment of the present invention.
As shown in fig. 6 to 9 and table 4. Delta E of cyanopyridine Compound of the present inventionSTBetween 0.02eV and 0.27eV, which is in accordance with the characteristics (Delta E) of the thermally activated delayed fluorescence moleculeST<0.3 eV). When Δ ESTSmaller, molecules tend to return from the triplet excited state to the singlet excited state more readily and emit delayed fluorescence.
In addition, as shown in table 4, PLQY of the cyanopyridine-containing compounds CzmPPC, tCzmPPC, TPAmPPC, sacmpc, TPAmPPC in the film was 92%, 97%, 100%, 79%, respectively, and excellent performance of these cyanopyridine-containing compounds in the film was expected. The pyridine-3, 5-dicyano has good molecular structure rigidity, and the steric barrier between the dimethyl on the phenyl (connecting group) and the dicyano on the pyridine can avoid non-radiative decline of molecular motion and the like, so that the cyanopyridine-containing compound can reach nearly 100% PLQY, and the cyanopyridine-containing compound has the potential of a high-efficiency TADF material and is beneficial to being applied to a light-emitting component.
[ test for Heat stability Properties ]
In the evaporation process of an OLED device, it is necessary to ensure that the compound does not decompose at high temperature and that a thin film of amorphous phase (amorphous) is formed to avoid crystallization hindering the transport of charges. In addition, during operation of the device, the excitons are exposed to a charged environment, and thus the compound has a high Bond Dissociation Energy (BDE).
In this example, thermogravimetric analysis was usedTGA (Thermogravimetric analysis, TGA) (Mettler-Toledo) company) was measured for the change in weight of a substance with respect to Temperature at a Temperature rising rate of 10 ℃ per minute under nitrogen to obtain thermal cracking temperatures (T) of the compounds of Synthesis examples 8 to 13 and Synthesis comparative example 1d) Wherein the thermal cracking temperature is defined as the temperature at which 5% by weight is lost. The thermal cracking temperatures of the compounds of synthesis examples 8 to 13 and synthesis comparative example 1 are shown in table 5 below.
[ measurement of delayed fluorescence Property ]
The compounds of Synthesis examples 8 to 13 and Synthesis example 1 were doped in 10 wt% respectively in a host material mCPCN and the above materials were evaporated on a quartz plate, an instantaneous light excitation spectrum was measured by an instantaneous light excitation spectrometer (Transient PL) Edinburgh FLS-S2S2-stm, and an instantaneous Fluorescence lifetime (τ) was calculated from the program F980p) Delayed Fluorescence lifetime (Delayed Fluorescence lifetime, tau)d) Instantaneous fluorescence emission quantum efficiency (phi)prompt) And delayed fluorescence emission quantum efficiency (phi)delayed) The results are shown in Table 5 below.
[ Table 5]
Synthesis examples Td(℃) τp(ns) τd(μs) Φprompt(%) Φdelayed(%)
CzmPPC 363 42 462 19 73
tCzmPPC 374 54 87 25 72
DBAZmPPC 371 15 0.1 5 19
SAcmPPC 400 99 72 16 84
TPAmPPC 336 33 3 9 91
tTPAmPPC 370 14 2 3 76
Comparative example of Synthesis Td(℃) τp(ns) τd(μs) Φprompt(%) Φdelayed(%)
TPAPPC 380 10 134 5 95
As is clear from the results in table 5, the thermal cracking temperature of the cyanopyridine-containing compound of the present invention is 336 to 400 ℃, and the thermal stability is excellent, so that it is ensured that cracking does not occur during the evaporation process.
In addition, the transient fluorescence lifetime (. tau.) of the cyanopyridine-containing compounds of the present inventionp) Are all less than 100 nanoseconds (ns), which represents the rapid light emission of the singlet excited state returning to the ground state, which is an important indicator of the delayed fluorescence property with thermal activation. Delayed fluorescence lifetime (τ) of cyanopyridine-containing compounds of the inventiond) Short, and delayed fluorescence emission quantum efficiency (phi)delayed) High in fluorescence and excellent in thermal activation delayed fluorescence property. The synthesized TPAPPC of comparative example has larger Delta E because the electron clouds of HOMO and LUMO are partially overlapped due to the lack of steric hindrance at the ortho-position of the phenyl groupSTResulting in a long delayed fluorescence lifetime of TPAPPC(134 microseconds (μ s)).
[ production of organic light-emitting diode ]
Experimental example 1
An organic light emitting diode was fabricated using 9- (3- (9H-carbazol-9-yl) phenyl) -9H-carbazolyl-3-carbonitrile (9- (3- (9H-carbazol-9-yl) phenyl) -9H-carbazole-3-carbonitrile, mCPCN) as a host light emitting material and the compound CzmPPC obtained in synthesis example 8 as a guest light emitting material (i.e., dopant).
Specifically, the manufacturing process of the organic light emitting diode is as follows: first, molybdenum trioxide (MoO) is deposited on an ITO glass substrate as an anode3) To form a hole injection layer. Then, deposit di- [4- (N, N-di (p-tolyl) amino) phenyl group on the hole injection layer]Cyclohexane, (1,1-bis [4- [ N, N' -di (p-tolyl) amino)]phenyl]cyclohexane, TAPC) to form a hole transport layer. Then, 1,3-bis (9-carbazolyl) benzene (1,3-bis (9-carbazolyl) benzene, mCP) was deposited on the hole transport layer to form an exciton blocking layer. Next, a host light emitting material mCPCN (20nm) doped with 10% of the compound CzmPPC was deposited to form a light emitting layer. Then, tri- [3- (3-pyridyl) 2,4, 6-trimethylphenyl is deposited on the light-emitting layer]Borane (3, 3' - [ borylidynylris (2,4, 6-trimethy-3, 1-phenylene)]tris[pyridine]3TPYMB) (50nm) to form an electron transport layer. Then, LiF (electron injection layer) (0.5nm) and Al were sequentially deposited on the electron transport layer to form a cathode. Thus, the organic light emitting diode of the present experimental example was manufactured. In this example, the cyanopyridine-containing compound CzmPPC of the present invention was used as an dopant.
The organic light emitting diode has the following structure: ITO/MoO3(1nm)/TAPC(50nm)/mCP(10nm)/mCPCN:CzmPPC(10wt%)(20nm)/3TPYMB(50nm)/LiF(0.5nm)/Al(100nm)。
Figure BDA0002846121460000231
Experimental example 2
An organic light emitting diode was formed using a method similar to that of experimental example 1, except that the compound tCzmPPC obtained in synthesis example 9 was used as a dopant for the light emitting layer.
Experimental example 3
An organic light emitting diode was formed using a method similar to that of experimental example 1, except that the compound DBAZmPPC obtained in synthesis example 10 was used as a dopant for the light emitting layer.
Experimental example 4
An organic light emitting diode was formed using a method similar to that of experimental example 1, except that the compound sacppc obtained in synthesis example 11 was used as a dopant of the light emitting layer.
Experimental example 5
An organic light emitting diode was formed using a method similar to that of experimental example 1, except that the compound TPAmPPC obtained in synthesis example 12 was used as a dopant for the light emitting layer.
Experimental example 6
An organic light emitting diode was formed using a method similar to that of experimental example 1, except that the compound tpamppc obtained in synthesis example 13 was used as a dopant for the light emitting layer.
Comparative example 1
An organic light emitting diode was formed using a method similar to that of experimental example 1, except that TPAPPC, the compound obtained in synthetic comparative example 1, was used as a dopant for the light emitting layer.
Comparative example 2
An organic light emitting diode was formed using a method similar to that of experimental example 1, except that the compound TPAsPPC was used as a dopant of the light emitting layer.
Figure BDA0002846121460000241
Comparative example 3
An organic light emitting diode was formed using a method similar to that of experimental example 1, except that the compound tCzmPMC was used as a dopant of the light emitting layer. In the structure of the compound tCzmPMC, the position 2 and 6 (R) of the pyridyl group in the core structure3) Introducing a firstAnd (4) a base.
Figure BDA0002846121460000242
[ evaluation of efficacy of organic light emitting diode ]
Fig. 10 is a photoexcitation emission spectrum of the organic light-emitting diodes of experimental examples 1 to 6. Table 6 shows the results of testing the performance of the organic light emitting diodes of experimental examples 1 to 6 and comparative examples 1 to 3. In this embodiment, the threshold voltage of the OLED is 1cd m-2The operating voltage of the time. The brightness, external quantum efficiency, luminous efficiency, and power efficiency of the organic light emitting diode are maximum values of the components, respectively. The emission wavelength and the CIE coordinates of the organic light emitting diode are the electroluminescence characteristics with an operating voltage of 8V.
[ Table 6]
Figure BDA0002846121460000243
Figure BDA0002846121460000251
As can be seen from fig. 10, the light emission wavelengths of the organic light emitting diodes of experimental examples 1 to 6 can range from sky blue (480nm) to yellow (556 nm). That is, with the nitrogen-containing group (R) at the para-position on the phenyl group3) The cyanopyridine-containing compounds of the present invention have different light emission colors. Thus, the present invention can be achieved by changing the nitrogen-containing group (R) of the cyanopyridine-containing compound3) The structure of the organic light emitting diode is used for regulating and controlling the light emitting color of the organic light emitting diode.
In addition, as can be seen from the results in table 6, the threshold voltages of the organic light emitting diodes of experimental examples 1 to 6 are all 3.0V or less (2.6V to 3.0V). The light emission wavelength of the organic light emitting diode (having the compound CzmPPC as a dopant) of experimental example 1 was 480nm, the maximum external quantum efficiency was 16.1% and the maximum light emission efficiency was 36.8cd a-1Maximum, maximumPower efficiency of 38.5lm W-1. The organic light emitting diode of experimental example 6 (having the compound tpamappc as a dopant) exhibited a light emission wavelength of 556nm, yellow light, a maximum external quantum efficiency of 29.8%, and a maximum light emission efficiency of 91.8cd a-1Maximum power efficiency of 96.1lm W-1
Among the above examples, the organic light emitting diodes of examples 4 (having the compound sacppc as an dopant) and 5 (having the compound TPAmPPC as an dopant) had more excellent device efficiency performance, and the maximum external quantum efficiencies thereof were 37.6% and 39.8%, respectively, and the maximum light emitting efficiency was 122.8cd a-1And 133.5cd A-1Maximum power efficiency of 128.6lm W-1And 139.8lm W-1Superior efficiency performance to typical TADF materials.
Fig. 11 is a luminance-external quantum efficiency curve of the organic light emitting diodes of experimental example 5, comparative example 1, and comparative example 2.
As can be seen from the results of fig. 11, the organic light emitting diodes of comparative examples 1 and 2 have a higher rate of decrease in external quantum efficiency as the luminance increases, as compared to the organic light emitting diode of experimental example 5. When in high brightness (1000cd m)-2) In the case of (1), the external quantum efficiency of the organic light emitting diode of comparative example 1 was only about 9.6%, which was much lower than that of experimental example 5 (27.0%). This is due to the greater Δ E of the compound TPAPCC of comparative example 1STTherefore, at high current densities, exciton-quenching or exciton-quenching is easily generated, resulting in loss of energy and efficiency. That is, the above results demonstrate that the introduction of two methyl groups at the ortho position of the phenyl group of the linking group (which can generate steric hindrance with the cyano group of the pyridyl group) can reduce the lifetime of delayed fluorescence, improve the efficiency of the light emitting device at high luminance, and thus can be more effectively applied to a display.
Fig. 12 is a luminance-external quantum efficiency curve of the organic light emitting diodes of experimental example 2 and comparative example 3.
Referring to fig. 12 and table 6, the maximum external quantum efficiency, the maximum luminous efficiency, and the maximum power efficiency of the organic light emitting diode of comparative example 3 are respectivelyOnly 3.2%, 4.6cd A-1And 4.2lm W-1Not only far below the efficiency performance of experimental example 2. In addition, the maximum external quantum efficiency of comparative example 3 is less than 5%, that is, the compound tCzmPMC of comparative example 3 does not have the characteristic of "the thermally activated delayed fluorescence molecule can improve the use ratio of the exciton by being transformed", and belongs to the conventional fluorescent material. The above results confirmed that the cyanopyridine-containing compounds of the present invention are present in the positions 2 and 6 (R) of the pyridyl group of the core structure3) The introduction of aromatic groups is important for the thermally activated delayed fluorescence properties and the luminous efficiency of the assembly.
[ component annealing test ]
In this example, the thermal stability of the cyanopyridine-containing compounds of the present invention was further tested via a thermal annealing (thermal annealing) experiment. After the organic light emitting diode is evaporated and packaged in a glove box under the nitrogen environment, the organic light emitting diode is placed on a heating plate. And then, heating at 50 ℃ and 80 ℃ for 20 minutes respectively, standing to return to room temperature after heating, and then carrying out electrical property test on the organic light-emitting diode.
In this example, the annealing test was performed using the organic light emitting diode of experimental example 5 (having the compound TPAmPPC as a dopant), and the results thereof are as follows in table 7.
[ Table 7]
Figure BDA0002846121460000271
Fig. 13 is a graph of luminance versus external quantum efficiency of the organic light emitting diode of experimental example 5 at different temperatures.
As can be seen from the results of FIG. 13 and Table 7, the OLED of Experimental example 5 exhibits a stability of a certain level even after being heated at 80 deg.C, and has a maximum external quantum efficiency of 29.0% and a maximum luminance of 14459cd m-2. In addition, as the heating temperature increased, the light emitting position and the threshold voltage of the organic light emitting diode of experimental example 5 were not changed, and the light leakage did not occur in the electroluminescence spectrum, which represents that the compound TPAmPPC was used as the light emitting diodeThe organic light-emitting guest material may have good thermal stability.
[ test of lifetime of light-emitting component ]
[ production of organic light-emitting diode ]
Experimental example 7
In this embodiment, the materials for fabricating the organic light emitting diode are in the following order: the anode is ITO, the hole injection layer is 1,4,5,8,9, 12-hexaazatriphenylene hexacarbonitrile (HAT-CN), the hole transport layer is 9,9 '-triphenyl-9H, 9H' -3,3',6',3 '-tricarbazole (9-Phenyl-3,6-bis (9-Phenyl-9Hcarbazol-3-yl) -9H-carbazole, Tris-PCz), the blocking layer is 1,3-bis (9-carbazolyl) benzene (1,3-bis (9-carbazolyl) benzene, mCP), the host material in the light emitting layer is 3,3' -bis (N-carbazolyl) -1,1 '-biphenyl (3, 3' -Di (9H-carbazol-9-yl) -1,1 '-biphenyl, mCBP), the cyanopyridine compound CzmPPC of the present invention is used as a guest material, the hole blocking layer is 2,4,6-tris ([1,1' -biphenyl ] -3-yl) -1,3,5-triazine (2,4,6-tris (biphenyl-3-yl) -1,3,5-triazine, T2T), the electron transport layer is 2,7-Bis ([2,2 '-bipyridine ] -5-yl) triphenylene (2,7-Bis (2, 2' -bipyridine-5-yl) triphenylene, BPy-TP2), the electron injection layer is LiF, and the cathode material is Al.
The organic light emitting diode has the following structure: ITO/HAT-CN (10nm)/Tris-PCz (30nm)/mCP (10nm)/mCBP 10 wt% guest material (30nm)/T2T (10nm)/BPy-TP2(40nm)/LiF (1.0nm)/Al (100 nm).
Figure BDA0002846121460000281
Experimental example 8
An organic light emitting diode was formed using a method similar to that of experimental example 7, except that the compound tCzmPPC obtained in synthesis example 9 was used as a dopant for the light emitting layer.
Experimental example 9
An organic light emitting diode was formed using a method similar to that of experimental example 7, except that the compound sacppc obtained in synthesis example 11 was used as a dopant of the light emitting layer.
Experimental example 10
An organic light emitting diode was formed using a method similar to that of experimental example 7, except that the compound TPAmPPC obtained in synthesis example 12 was used as a dopant for the light emitting layer.
Experimental example 11
An organic light emitting diode was formed using a method similar to that of experimental example 7, except that the compound tpamappc obtained in synthesis example 13 was used as a dopant for the light emitting layer.
Comparative example 4
An organic light emitting diode was formed using a method similar to that of experimental example 7, except that TPAPPC, the compound obtained in synthetic comparative example 1, was used as a dopant for the light emitting layer.
The half-life test mode of the component is 1000cd m in brightness-2As the initial brightness (L)0=1000cd m-2) The luminance of the OLED is measured to be reduced to half (L500 cd m)-2) The measurement results of the elapsed time are shown in Table 8 below. Fig. 14 shows the results of the lifetime test of the light emitting devices of experimental example 10, experimental example 11, and comparative example 4.
[ Table 8]
Figure BDA0002846121460000291
As can be seen from the results of fig. 14 and table 8, the half-life of the device of the organic light emitting diode of experimental example 10 (having the compound TPAmPPC as a dopant) was the longest, reaching 208 hours, and was significantly better than the half-life of the device of the organic light emitting diode of comparative example 4 (having the compound tpapppc as a dopant) (3 hours). This is because the TPAmPPC compound has a short delayed fluorescence lifetime, thereby reducing the time that the material is in an exciton, avoiding the reaction with holes, electrons and excitons in the environment, further avoiding the breakage of non-radiative decay paths or chemical bonds, and greatly improving the stability of the light emitting device.
The cyanopyridine compound of the present invention has excellent heat activated delayed fluorescence characteristic as the guest material of organic light emitting diode component andthe molecular rigidity can shorten the life time of delayed fluorescence by changing the electron-pushing group at the para position of the phenyl and introducing the double methyl group at the ortho position of the phenyl, thereby achieving rapid reverse intersystem crossing (RISC) and 100 percent of luminous quantum efficiency so as to effectively utilize an exciton. In addition, the electroluminescent assembly made of the cyanopyridine compound has assembly efficiency as high as 40% and maximum brightness as high as 15256cd m-2And at high brightness (1000cd m)-2) The external quantum efficiency can still maintain 27.0 percent and meet the specification required by practical application.
In addition, the good stability of the cyanopyridine-containing compounds of the present invention was further demonstrated via annealing assembly tests and lifetime assembly tests, consistent with the long-term operation of the panels.
Although the present invention has been described with reference to the above embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.

Claims (10)

1. A cyanopyridine compound represented by the following chemical formula 1:
[ chemical formula 1]
Figure FDA0002846121450000011
In the chemical formula 1, the first and second,
Ar1and Ar2May be the same or different and are each independently substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl;
R1and R2May be the same or different and are each independently substituted or unsubstituted alkyl; and
R3is a nitrogen-containing group.
2. The cyanopyridine-containing compound of claim 1, wherein R3Any one selected from the following structures:
Figure FDA0002846121450000012
3. the cyanopyridine compound of claim 1, wherein Ar1And Ar2Each independently is any one selected from the following structures:
Figure FDA0002846121450000021
4. the cyanopyridine-containing compound of claim 1, wherein R1And R2Each independently being methyl, ethyl or propyl.
5. The cyanopyridine-containing compound of claim 1, wherein the cyanopyridine-containing compound is selected from any one of the following structural formulae:
Figure FDA0002846121450000022
Figure FDA0002846121450000031
6. an electroluminescent device comprising:
a cathode;
an anode; and
a light-emitting layer disposed between the cathode and the anode, the light-emitting layer comprising the cyanopyridine compound of any one of claims 1-5.
7. The electroluminescent device of claim 6, wherein the light-emitting layer comprises a host light-emitting material and a guest light-emitting material.
8. The electroluminescent device of claim 7, wherein the host luminescent material comprises the cyanopyridine compound.
9. The electroluminescent device of claim 7, wherein the guest emissive material comprises the cyanopyridine-containing compound.
10. The electroluminescent device of claim 6, further comprising at least one auxiliary layer selected from the group consisting of a hole injection layer, a hole transport layer, a hole blocking layer, an exciton blocking layer, an electron injection layer, an electron transport layer, and an electron blocking layer.
CN202011510063.3A 2020-12-18 2020-12-18 Cyanopyridine compound and electroluminescent device comprising the same Pending CN114644617A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011510063.3A CN114644617A (en) 2020-12-18 2020-12-18 Cyanopyridine compound and electroluminescent device comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011510063.3A CN114644617A (en) 2020-12-18 2020-12-18 Cyanopyridine compound and electroluminescent device comprising the same

Publications (1)

Publication Number Publication Date
CN114644617A true CN114644617A (en) 2022-06-21

Family

ID=81991555

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011510063.3A Pending CN114644617A (en) 2020-12-18 2020-12-18 Cyanopyridine compound and electroluminescent device comprising the same

Country Status (1)

Country Link
CN (1) CN114644617A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113224247A (en) * 2021-02-19 2021-08-06 冠能光电材料(深圳)有限责任公司 Pyridine-3, 5-dinitrile-based electroluminescent material and application thereof in organic light-emitting device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109535131A (en) * 2018-12-25 2019-03-29 西安瑞联新材料股份有限公司 It is a kind of using cyanopyridine as the compound of receptor and its application
US20190296246A1 (en) * 2015-06-23 2019-09-26 Kaneka Corporation Organic el material and organic el element employing same
CN113105435A (en) * 2021-04-13 2021-07-13 南京益米昇光电科技有限公司 Thermal activation delayed fluorescence material based on cyanopyridine, preparation method thereof and application thereof in organic electroluminescence

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190296246A1 (en) * 2015-06-23 2019-09-26 Kaneka Corporation Organic el material and organic el element employing same
CN109535131A (en) * 2018-12-25 2019-03-29 西安瑞联新材料股份有限公司 It is a kind of using cyanopyridine as the compound of receptor and its application
CN113105435A (en) * 2021-04-13 2021-07-13 南京益米昇光电科技有限公司 Thermal activation delayed fluorescence material based on cyanopyridine, preparation method thereof and application thereof in organic electroluminescence

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEN, YI-KUAN ET AL.,: ""Increase the molecular length and donor strength to boost horizontal dipole orientation for high-efficiency OLEDs"", 《J. MATER. CHEM. C》, vol. 10, no. 24, pages 9241 - 9248 *
DENG, SHENG-LIN ET AL.,: ""Modifications of Pyridine-3, 5-dicarbonitrile Acceptor for Highly Efficient Green-to-Red Organic Light-Emitting Diodes"", 《ACS APPLIED MATERIALS & INTERFACES》, vol. 15, no. 28, pages 33819 - 33828 *
HE LIU ET AL.,: ""A Simple Strategy to Achieve Efficient Thermally Activated Delayed Fluorescent Emitters via Enhancing Electron-donating Ability of Donors"", 《"A SIMPLE STRATEGY TO ACHIEVE EFFICIENT THERMALLY ACTIVATED DELAYED FLUORESCENT EMITTERS VIA ENHANCING ELECTRON-DONATING ABILITY OF DONORS"》, vol. 2020, no. 180, pages 1 - 7 *
XUDONG CAO ET AL.,: ""CN-Containing donor–acceptor-type small-molecule materials for thermally activated delayed fluorescence OLEDs"", 《J. MATER. CHEM. C》, vol. 2017, no. 5, pages 7699 *
YI-KUAN CHEN, ET AL.,: ""Triarylamine-Pyridine-Carbonitriles for Organic Light- Emitting Devices with EQE Nearly 40%"", 《ADV. MATER》, vol. 2021, pages 1 - 8 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113224247A (en) * 2021-02-19 2021-08-06 冠能光电材料(深圳)有限责任公司 Pyridine-3, 5-dinitrile-based electroluminescent material and application thereof in organic light-emitting device

Similar Documents

Publication Publication Date Title
JP7336412B2 (en) Organic alloy for organic optoelectronic device, organic optoelectronic device and display device
Liao et al. Hydroxynaphthyridine-derived group III metal chelates: wide band gap and deep blue analogues of green Alq3 (tris (8-hydroxyquinolate) aluminum) and their versatile applications for organic light-emitting diodes
Mallesham et al. Phosphine oxide functionalized pyrenes as efficient blue light emitting multifunctional materials for organic light emitting diodes
JP6493220B2 (en) Luminescent material, organic light emitting device and compound
JP5727376B2 (en) Novel organic light emitting compound and organic light emitting device including the same
JP5718353B2 (en) Organic compounds for electroluminescent devices
JP4947142B2 (en) Light emitting device material and light emitting device
Bian et al. A combinational molecular design to achieve highly efficient deep-blue electrofluorescence
JP2014523877A (en) NOVEL COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME
KR20100106014A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
TW201348228A (en) Material for organic electroluminescent element, and element using same
KR20110008723A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20130075982A (en) Anthracene-based compound and organic electroluminescence device using the same
TW201343639A (en) Material for organic electroluminescence element and element using same
KR20140090133A (en) Material for organic electroluminescent elements, and organic electroluminescent element using same
JP2024510490A (en) Composition for organic optoelectronic devices, organic optoelectronic devices and display devices
JP2018035129A (en) Pyrimidine derivative, luminescent material consisting of the same and organic el element using the same
CN112239452B (en) Electron transport type heteroanthracene derivative and organic electroluminescent device thereof
Chen et al. Full-colour luminescent compounds based on anthracene and 2, 2′-dipyridylamine
KR101661592B1 (en) fused fluoranthene derivatives and organic electroluminescent device including the same
KR101815653B1 (en) Azaboradibenzochrysene derivatives organic electroluminescent compound, ink composition and organic electroluminescent device
CN114644617A (en) Cyanopyridine compound and electroluminescent device comprising the same
TWI742965B (en) Pyridine-carbonitrile compound and electroluminescent device including the same
TWI630260B (en) Quinoline-substituted diphenylpyrimidines compounds and organic electroluminescent devices using the same
CN114014881B (en) Narrow-emission efficient multi-resonance luminescent material, preparation method thereof and organic light-emitting diode

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination